
Organometallic Ligands
In this category, you will be able to find a large number of organometallic molecules used as ligands in biomolecules. These organometallic ligands can be used in organic chemistry and synthesis in the laboratory. They play a critical role in forming coordination complexes and catalyzing various chemical reactions. At CymitQuimica, we offer a diverse selection of high-quality organometallic ligands to support your research and industrial needs.
Subcategories of "Organometallic Ligands"
- Buchwald Ligands(22 products)
- DPEN(4 products)
- DPHEN(4 products)
- JOSIPHOS(4 products)
- Phosphine(497 products)
- Porphirines(75 products)
Found 2887 products of "Organometallic Ligands"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(R,R)-Palonosetron hydrochloride
CAS:<p>Antagonist of serotonin receptors 5-HT3</p>Formula:C19H25ClN2OPurity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:332.87 g/molAlectinib hydrochloride
CAS:<p>An active product of vitamin A metabolism. Activates RXR and RAR receptor isoforms with high binding affinity. Induces differentiation of neural stem cells into neurons.</p>Formula:C30H34N4O2·HClPurity:Min. 95%Color and Shape:Off-White To Beige SolidMolecular weight:519.08 g/molGBR 12935
CAS:<p>Dopamine reuptake inhibitor</p>Formula:C28H34N2OPurity:Min. 95%Molecular weight:414.26711Apatinib
CAS:<p>Apatinib, also known as rivoceranib, is an inhibitor of the vascular endothelial growth factor receptor 2 (VEGFR2) tyrosine kinase. Apatinib targets VEGFR2 with its action and has proven to have strong anti-tumor effects in human cancers. In studies in mice, apatinib acted as an Inhibitor of VEGFR2 and played an antiangiogenic effect. Apatinib has been suggested for the treatment of ischemia-induced proliferative retinopathy and neovascular age-related macular degeneration.</p>Formula:C24H23N5OPurity:Min. 95%Color and Shape:PowderMolecular weight:397.47 g/molBosutinib
CAS:<p>Inhibitor of Abl and Src kinases; anti-proliferative; antineoplasticÂ</p>Formula:C26H29Cl2N5O3Purity:Min. 95%Color and Shape:Off-White PowderMolecular weight:530.45 g/molBenziodarone
CAS:<p>Uricosuric agent</p>Formula:C17H12I2O3Purity:Min. 95%Color and Shape:Beige PowderMolecular weight:518.08 g/molTolrestat
CAS:<p>Aldose reductase AKR1B10 inhibitor; hepatotoxic</p>Formula:C16H14F3NO3SPurity:Min. 95%Molecular weight:357.35 g/molFlavopiridol
CAS:<p>Inhibitor of CKD1, CDK2, and CDK4 serine/threonine kinases</p>Formula:C21H20ClNO5Purity:Min. 95%Color and Shape:Light (Or Pale) Yellow To Yellow SolidMolecular weight:401.103c16(Plasm) lpc
CAS:<p>C16(Plasm) LPC is a lysophosphatidylcholine, a type of lysophospholipid derived predominantly from plasma membrane phospholipids. It originates from the enzymatic action of phospholipase A2, which cleaves the fatty acid chain, typically at the sn-2 position. This leaves behind the lysophospholipid with a single acyl chain.</p>Formula:C24H50NO6PPurity:Min. 95%Molecular weight:479.63 g/molTemocapril hydrochloride
CAS:<p>Angiotensin-converting enzyme inhibitor; anti-hypertensive</p>Formula:C23H29ClN2O5S2Purity:Min. 95%Color and Shape:SolidMolecular weight:513.07 g/molMG 132
CAS:<p>MG 132 is a modified tripeptide that acts as proteasomal inhibitor. In 2006, MG 132 has been experimentally tested in in vitro cell-based and in vivo models for to assess its use in the medical treatment of Parkinson's disease.</p>Formula:C26H41N3O5Purity:Min. 95%Color and Shape:PowderMolecular weight:475.30462Cetrorelix acetate
CAS:<p>Synthetic antagonist of GnRH receptor</p>Formula:C70H92ClN17O14Purity:Min. 95%Color and Shape:White/Off-White SolidMolecular weight:1429.66982Brompheniramine maleate
CAS:<p>Histamine (H1) antagonist; used to treat allergies, rhinitis and urticaria</p>Formula:C20H23BrN2O4Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:435.31 g/molRaltitrexed
CAS:<p>Anti-folate inhibitor of thymidylate synthase</p>Formula:C21H22N4O6SPurity:Min. 95%Color and Shape:SolidMolecular weight:458.49 g/molVoxelotor
CAS:Controlled Product<p>Voxelotor is an oral therapeutic agent, which is a small molecule obtained through synthetic chemistry with targeted activity on hemoglobin. Its mode of action involves the allosteric modification of hemoglobin, specifically increasing hemoglobin oxygen affinity. By stabilizing the oxygenated hemoglobin state, voxelotor reduces the sickling and polymerization of red blood cells that are characteristic of sickle cell disease (SCD).</p>Formula:C19H19N3O3Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:337.37 g/molCeralifimod
CAS:<p>Please enquire for more information about Ceralifimod including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C27H33NO4Purity:Min. 95%Molecular weight:435.56 g/molDeferasirox Fe3+ Chelate
CAS:<p>Iron chelator</p>Formula:C21H12FeN3O4Purity:Min. 95%Molecular weight:426.18 g/molZofenopril calcium
CAS:<p>Angiotensin-converting enzyme inhibitor; antioxidant</p>Formula:C44H46N2O8S4•CaPurity:Min. 95%Color and Shape:PowderMolecular weight:899.17 g/molPitofenone hydrochloride
CAS:<p>Inhibits acetylcholinesterase (AChE); antispasmodic agent</p>Formula:C22H25NO4·ClHPurity:Min. 95%Molecular weight:403.9 g/molN-Acetyl-DL-penicillamine
CAS:<p>Protective agent against mercuric chloride poisoning</p>Formula:C7H13NO3SPurity:Min. 95%Color and Shape:PowderMolecular weight:191.25 g/mol
